Morphologic Patterns on Spectral-Domain Optical Coherence Tomography (SD-OCT) as a Prognostic Indicator in Treatment of Macular Edema Due to Retinal Vein Occlusion;Morphologische Kriterien in der hochauflösenden optischen Kohärenztomografie (SD-OCT) als prognostischer Faktor der Behandlung des Makulaödems bei retinalen venösen Verschlüssen

Klinische Monatsblatter fur Augenheilkunde

Volumn 233, Issue 9, 2016, Pages 1056-1062

  Groneberg, T ^a   Trattnig, J S ^a   Feucht, N ^a   Lohmann, C P ^a   Maier, M ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

macular edema; optical coherence tomography; retina; vein occlusion

Indexed keywords

DEXAMETHASONE; RANIBIZUMAB; ANGIOGENESIS INHIBITOR;

ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; EPIRETINAL MEMBRANE; HUMAN; MACULAR EDEMA; MAJOR CLINICAL STUDY; PROGNOSIS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL FLUID; VISUAL ACUITY; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; DRUG MONITORING; FEMALE; INTRAVITREAL DRUG ADMINISTRATION; MALE; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; DEXAMETHASONE; DRUG MONITORING; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; PROGNOSIS; RANIBIZUMAB; REPRODUCIBILITY OF RESULTS; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84957828000     PISSN: 00232165     EISSN: 14393999     Source Type: Journal    
DOI: 10.1055/s-0041-108680     Document Type: Article

References (22)

1. Jaulim A., Ahmed B., Khanam T. et al. Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature. Retina: 2013; 33 901 910
2. Klein R., Klein B. E., Moss S. E. et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc: 2000; 98 133 141
3. Feltgen N. Venenverschlüsse. In: Kellner U., Wachtlin J. Hrsg. Retina: Diagnostik und Therapie der Erkrankungen des hinteren Augenabschnitts. Stuttgart Thieme: 2008; 207 214
4. Haller J. A., Bandello F., Belfort R. et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology: 2010; 117 1134 1146
5. Brown D. M., Campochiaro P. A., Bhisitkul R. B. et al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study. Ophthalmology: 2011; 118 1594 1602
6. Campochiaro P. A., Brown D. M., Awh C. C. et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology: 2011; 118 2041 2049
7. Brown D. M., Heier J. S., Clark W. L. et al. Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study. Am J Ophthalmol: 2013; 155 429 437
8. Korobelnik J. F., Holz F. G., Roider J. et al. Intravitreal aflibercept injection for macular edema resulting from central vein occlusion: one-year results of the phase 3 GALILEO study. Ophthalmology: 2014; 121 202 208
9. [Anonymous] Central vein occlusion study of photocoagulation therapy. Baseline findings. Central Vein Occlusion Study Group. Online J Curr Clin Trials: 1993; Doc No 95
10. [Anonymous] Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol: 1997; 115 486 491
11. [Anonymous] Argon-laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Retinal Occlusion Study Group. Am J Ophthalmol: 1984; 98 271 282
12. Decroos F. C., Stinnett S. S., Heydary C. S. et al. Reading center characterization of retinal vein occlusion using optical coherence tomography during the COPERNICUS Trial. Trans Vis Sci Technol: 2013; 2 7
13. Bhisitkul R. B., Campochiaro P. A., Shapiro H. et al. Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography. Ophthalmology: 2013; 120 1057 1063
14. Kang H. M., Chung E. J., Kim Y. M. et al. Spectral-domain optical coherence tomography (SD-OCT) patterns and response to intravitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol: 2013; 251 501 508
15. Campochiaro P. A., Heier J. S., Feiner L. et al. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology: 2010; 117 1102 1112
16. Sheu S. J., Wu T. T., Horng Y. H. Efficacy and safety of dexamethasone intravitreal implant for treatment of refractory macular edema secondary to retinal vein occlusion in Taiwan. J Ocul Pharmacol Ther: 2015; 31 461 467
17. Wai C. L., David A. A., Pradeepa Y. et al. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study. Clin Ophthalmol: 2015; 9 1255 1268
18. Augustin A. J., Holz F. G., Haritoglou C. et al. Retrospective, observational study in patients receiving a dexamethasone intravitreal implant 0.7 mg for macular oedema secondary to retinal vein occlusion. Ophthalmologica: 2015; 233 18 26
19. Schmitz K., Maier M., Clemens C. R. et al. [Reliability and safety of intravitreal Ozurdex injections. The ZERO study]. Ophthalmologe: 2014; 111 44 52
20. Bezatis A., Spital G., Höhn F. et al. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up - the SOLO study. Acta Ophthalmol: 2013; 91 e340 e347
21. Brown D. M., Campochiaro P. A., Singh R. P. et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology: 2010; 117 1124 1133
22. Hoeh A. E., Ruppenstein M., Ach T. et al. OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol: 2010; 248 1567 1572